{"id":20605,"date":"2021-04-21T13:36:00","date_gmt":"2021-04-21T13:36:00","guid":{"rendered":"https:\/\/dejalex.com\/it\/2021\/04\/gilead-sciences-challenges-the-grant-by-the-russian-government-of-the-right-to-use-without-consent-its-patents-for-medicines-employed-in-the-covid-19-therapy\/"},"modified":"2021-04-26T13:41:20","modified_gmt":"2021-04-26T13:41:20","slug":"gilead-sciences-challenges-the-grant-by-the-russian-government-of-the-right-to-use-without-consent-its-patents-for-medicines-employed-in-the-covid-19-therapy","status":"publish","type":"post","link":"https:\/\/www.dejalex.com\/it\/2021\/04\/gilead-sciences-challenges-the-grant-by-the-russian-government-of-the-right-to-use-without-consent-its-patents-for-medicines-employed-in-the-covid-19-therapy\/","title":{"rendered":"GILEAD SCIENCES CHALLENGES THE GRANT BY THE RUSSIAN GOVERNMENT OF THE RIGHT TO USE WITHOUT CONSENT ITS PATENTS FOR MEDICINES EMPLOYED IN THE COVID- 19 THERAPY"},"content":{"rendered":"<p>In January 2021 it became public that the Russian Government had granted right to use 5 patents owned by Gilead Sciences, Inc. in relation to medicines employed in the therapy of COVID-19 without the consent of the patent holder&#8230;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2114 aligncenter\" src=\"https:\/\/dejalex.com\/it\/wp-content\/uploads\/2021\/04\/Article_Gilead-endavors-to-invalidate-grant-of-license-to-Pharmasintez-without-its-consent.jpg\" alt=\"\" width=\"557\" height=\"789\"><\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/dejalex.com\/it\/wp-content\/uploads\/2021\/04\/Article_Gilead-endavors-to-invalidate-grant-of-license-to-Pharmasintez-without-its-consent.pdf\" target=\"_blank\" rel=\"noopener\"><i  class=\"x-icon x-icon-download\" data-x-icon-s=\"&#xf019;\" aria-hidden=\"true\"><\/i> Scarica l&#8217;articolo<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[x_icon type=\"tag\"] Coronavirus, Propriet\u00e0 Intellettuale, Farmaceutico e Life Sciences, Russia<\/p>\n","protected":false},"author":3,"featured_media":17673,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[429,439,370,341,422,239,427],"tags":[],"class_list":["post-20605","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alisa-pestryakova-it","category-coronavirus-it","category-farmaceutico-e-life-sciences","category-proprieta-intellettuale","category-pubblicazioni","category-russia-it","category-russian-brief-it"],"_links":{"self":[{"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/posts\/20605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/comments?post=20605"}],"version-history":[{"count":1,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/posts\/20605\/revisions"}],"predecessor-version":[{"id":20606,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/posts\/20605\/revisions\/20606"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/media\/17673"}],"wp:attachment":[{"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/media?parent=20605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/categories?post=20605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dejalex.com\/it\/wp-json\/wp\/v2\/tags?post=20605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}